Defective Activation of Clotting, Fibrinolytic, and Permeability-Enhancing Systems in Human Fletcher Trait Plasma
- 1 May 1974
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 34 (5), 641-651
- https://doi.org/10.1161/01.res.34.5.641
Abstract
When normal plasma is exposed to foreign surfaces, Hageman factor (HF, factor XII) is activated; under appropriate circumstances, it then initiates reactions leading to coagulation, fibrinolysis, increased vascular permeability, esterolytic activity, and kinin formation. However, coagulation, fibrinolysis, and increased vascular permeability were impaired in plasma from an individual with Fletcher trait, despite a normal concentration of HF that is functionally and immunologically indistinguishable from that in normal plasma. This defective clotting is completely repaired by the addition of small amounts of normal plasma, HF-deficient plasma, plasma thrombo-plastin antecedent (PTA)-deficient plasma, or activated PTA but only partially repaired by the addition of activated HF. Defective fibrinolysis and permeability-enhancing activity were partially corrected by the addition of small amounts of normal plasma, HF-deficient plasma, PTA-deficient plasma, or activated HF. A preparation of partially purified plasma kallikrein largely repaired defective coagulation and fibrinolysis in Fletcher trait plasma in the presence of kaolin. In immunodif fusion studies, no precipitin line formed between Fletcher trait plasma and monospecific antikallikrein serum. Fletcher trait plasma appeared to be deficient in a plasma prekallikrein, which most probably participates in the functioning of activated HF. These studies emphasize the intimate relationships among clotting, fibrinolysis, and enhancement of vascular permeability.Keywords
This publication has 19 references indexed in Scilit:
- Partial Purification of Plasma Thromboplastin Antecedent (Factor XI) and its Activation by TrypsinJCI Insight, 1973
- The Assay of a Plasma Component Necessary for the Generation of a Plasminogen Activator in the Presence of Hageman Factor (Hageman Factor Co-factor)British Journal of Haematology, 1971
- Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's diseaseJCI Insight, 1971
- Fletcher Factor Deficiency: A Report of Three Unrelated CasesBritish Journal of Haematology, 1970
- The Relation of ‘Fletcher Factor’ to Factors XI and XIIBritish Journal of Haematology, 1970
- Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactorsJCI Insight, 1969
- THE ENZYMATIC NATURE OF C'1rThe Journal of Experimental Medicine, 1968
- Hageman Factor: Alterations in Physical Properties during ActivationScience, 1965
- Role of Hageman Factor in the Activation of Vasodilator Activity in Human PlasmaNature, 1961
- Activation of a Permeability Factor in Plasma by Contact with GlassNature, 1958